Quince Therapeutics, Inc. (QNCX)
USD 1.85
(0.54%)
USD 1.85
(0.54%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -18.29 Million | -44.03 Million | -62.93 Million | -50.81 Million | -33.27 Million | -11.69 Million |
| Net Income | -31.38 Million | -51.66 Million | -89.94 Million | -76.84 Million | -36.98 Million | -12.47 Million |
| Depreciation & Amortization | 322 Thousand | 204 Thousand | 344 Thousand | 332 Thousand | 188 Thousand | 51 Thousand |
| Deferred income taxes | -248 Thousand | -284 Thousand | 878 Thousand | 635 Thousand | -812 Thousand | -145 Thousand |
| Stock-based compensation | 5.22 Million | 16.61 Million | 29.85 Million | 14.47 Million | 2.05 Million | 155 Thousand |
| Change in working capital | 1.97 Million | -9.82 Million | -4.26 Million | 10.22 Million | 1.9 Million | -390 Thousand |
| Other non-cash items | 5.82 Million | 913 Thousand | 199 Thousand | 367 Thousand | 367 Thousand | 1.11 Million |
| Investing Cash Flow | -5.75 Million | 18 Million | 58.95 Million | -52.43 Million | -17.74 Million | -46.75 Million |
| Investments in PPE | -160 Thousand | -133 Thousand | -180 Thousand | -52 Thousand | -55 Thousand | -212 Thousand |
| Acquisitions | -2.02 Million | 10.59 Million | -58.95 Million | 52.43 Million | -812 Thousand | - |
| Investment purchases | -113.78 Million | -75.02 Million | -38.78 Million | -187.14 Million | -135.41 Million | -55.24 Million |
| Sales/Maturities of investments | 111.2 Million | 82.49 Million | 97.92 Million | 134.76 Million | 117.72 Million | 8.7 Million |
| Other Investing Activities | -1 Million | 70 Thousand | 58.95 Million | -52.43 Million | 812 Thousand | -46.54 Million |
| Financing Cash Flow | 143 Thousand | 707 Thousand | 6.8 Million | 118.87 Million | 77.36 Million | 75.92 Million |
| Debt repayment | -6000.00 | -49 Thousand | - | -34 Thousand | -559 Thousand | -250 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 63.73 Million | 16.5 Million | - | - | - | - |
| Common Stock Issuance | 149 Thousand | 608 Thousand | 6.8 Million | 118.91 Million | 77.82 Million | 75.67 Million |
| Other Financing Activities | 149 Thousand | -16.35 Million | 6808.00 | 118.91 Million | 98 Thousand | 75.92 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -288 Thousand | -5.94 Million | 1.35 Million | 480 Thousand | 2.58 Million | -23 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2.26 Million | -3.88 Million | -5.61 Million | 9.74 Million | -676 Thousand | -367 Thousand |
| Cash at beginning of period | 44.57 Million | 69.72 Million | 66.84 Million | 51.21 Million | 24.87 Million | 7.39 Million |
| Cash at end of period | 20.75 Million | 44.57 Million | 69.72 Million | 66.84 Million | 51.21 Million | 24.87 Million |
| Capital Expenditure | -160 Thousand | -133 Thousand | -180 Thousand | -52 Thousand | -55 Thousand | -212 Thousand |
| Effect of forex changes on cash | 80 Thousand | 184 Thousand | 55 Thousand | - | - | - |
| Net cash flow / Change in cash | -23.82 Million | -25.14 Million | 2.88 Million | 15.62 Million | 26.34 Million | 17.47 Million |
| Free Cash Flow | -18.45 Million | -44.17 Million | -63.11 Million | -50.87 Million | -33.33 Million | -11.9 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -27.72 Million | -11.14 Million | -31.38 Million | -8.89 Million | -5.35 Million | -4.88 Million |
| Depreciation & Amortization | 44 Thousand | 40 Thousand | 322 Thousand | 304 Thousand | - | 1000.00 |
| Deferred income taxes | - | - | -248 Thousand | -1.82 Million | - | 856 Thousand |
| Stock-based compensation | 1.22 Million | 1.27 Million | 5.22 Million | 1.08 Million | 1.33 Million | 1.32 Million |
| Change in working capital | -1.42 Million | -805 Thousand | 1.97 Million | 250 Thousand | -79 Thousand | 201 Thousand |
| Other non-cash items | 20.11 Million | 3.58 Million | 5.82 Million | 2.99 Million | -719 Thousand | -1.32 Million |
| Investing Cash Flow | -4.97 Million | 8.91 Million | -5.75 Million | 5.39 Million | 3.63 Million | -20.32 Million |
| Investments in PPE | -39 Thousand | -39 Thousand | -160 Thousand | -24 Thousand | - | - |
| Acquisitions | - | - | -2.02 Million | -2.11 Million | - | - |
| Investment purchases | -46.42 Million | -39.29 Million | -113.78 Million | -18.66 Million | -44.98 Million | -42.44 Million |
| Sales/Maturities of investments | 41.49 Million | 48.24 Million | 111.2 Million | 26.69 Million | 49.12 Million | 22.11 Million |
| Other Investing Activities | -4.93 Million | 8.95 Million | -1 Million | -500 Thousand | -500 Thousand | -20.32 Thousand |
| Financing Cash Flow | 35 Thousand | 190 Thousand | 143 Thousand | 57 Thousand | 10 Thousand | 26 Thousand |
| Debt repayment | - | - | -6000.00 | -6000.00 | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | 63.73 Million | 63.73 Million | - | - |
| Common Stock Issuance | 35 Thousand | 190 Thousand | 149 Thousand | 57 Thousand | 10 Thousand | 26 Thousand |
| Other Financing Activities | 35 Thousand | 190 Thousand | 149 Thousand | 57 Thousand | 10 Thousand | 26 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 342 Thousand | 59 Thousand | -288 Thousand | -127 Thousand | 55 Thousand | -1.29 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.76 Million | -864 Thousand | 2.26 Million | 377 Thousand | -134 Thousand | 1.49 Million |
| Cash at beginning of period | 21.81 Million | 20.75 Million | 44.57 Million | 21.63 Million | 22.65 Million | 46.71 Million |
| Cash at end of period | 7.89 Million | 21.81 Million | 20.75 Million | 20.75 Million | 21.63 Million | 22.65 Million |
| Capital Expenditure | -39 Thousand | -39 Thousand | -160 Thousand | -24 Thousand | - | - |
| Effect of forex changes on cash | -241 Thousand | 310 Thousand | 80 Thousand | -249 Thousand | 155 Thousand | 60 Thousand |
| Net cash flow / Change in cash | -13.92 Million | 1.06 Million | -23.82 Million | -880 Thousand | -1.01 Million | -24.06 Million |
| Free Cash Flow | -8.77 Million | -8.39 Million | -18.45 Million | -6.1 Million | -4.81 Million | -3.82 Million |
USLG
PEIMF
RGLSF
ARH
QEC
CCLINTER